Virtus Pharmaceuticals OPCO II, LLC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Virtus Pharmaceuticals OPCO II, LLC

Sort by

Viewing results 1‒5 of 5

FT Alphaville
How to spend a million dollars, by Sam Bankman-Fried
...Race Capital II, LP . . . Lifelike Capital [ridiculously minimalist website award winner] . . . ....
December 19, 2022
US & Canadian companies
Activist hedge funds found wanting in essential tasks
...Activist hedge funds have been on site at an accumulating number of corporate disasters, of which the plunging share price of Valeant Pharmaceuticals is just the latest....
March 29, 2016
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
FT AlphavilleMergers & Acquisitions
Shkreli’s new target market: 1100 Americans-a-year
...It recently failed basic Phase II trials as an asthma treatment. That was the previous management’s last hope. But the plan now is to try lenzilumab on a form of leukaemia, known as CMML....
November 24, 2015
Banks
SAC’s Cohen charged over insider trading
...The hedge fund has agreed a $602m settlement of civil charges with the SEC relating to trading in two pharmaceutical stocks, Elan and Wyeth, without admitting or denying wrongdoing....
July 19, 2013
ReviewFT & McKinsey Business Book of the Year Award
Extracts from the 2014 shortlist
...The website was also selling data about its members to pharmaceutical and other companies. The news was a double betrayal for Sharon and Bilal....
October 8, 2014

Previous pagePage 1 of 1Next page